7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      The US economic and social costs of Alzheimer's disease revisited.

      ,

      American Journal of Public Health

      American Public Health Association

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          OBJECTIVEs. An earlier paper estimated the per-case and national incidence costs of Alzheimer's disease for 1983. This paper updates the estimates of costs per case to 1991 and presents new national prevalence estimates of the economic and social costs of the disease. All data for the cost estimates were taken from published sources or provided by other researchers. At midrange values of the estimated cost and epidemiological parameters, the discounted (at 4%) direct and total costs of Alzheimer's disease were $47,581 and $173,932 per case, respectively. The estimated 1991 national direct and total prevalence costs were $20.6 billion and $67.3 billion, respectively. Assuming conservatively that the prevalence of the disease remains constant, the estimated discounted present values of the direct and total costs of all current and future generations of Alzheimer's patients are $536 billion and $1.75 trillion, respectively. The $536 billion and $1.75 trillion figures are minimum estimates of the long-term dollar losses to the US economy in 1991 caused by Alzheimer's disease.

          Related collections

          Most cited references 30

          • Record: found
          • Abstract: not found
          • Article: not found

          Caregiver well-being: a multidimensional examination of family caregivers of demented adults.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Chronic stress and immunity in family caregivers of Alzheimerʼs disease victims.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Predictors of institutionalization among caregivers of patients with Alzheimer's disease.

              The treatment aim of medical care for home-based patients with Alzheimer's disease is to maximize the functioning level of the patient without jeopardizing quality of life for the caregiver. Most demented elderly live in the community with their families who, until coping becomes ineffective, usually prefer to keep their relatives out of institutions for as long as possible. In the present study, the question of why some families continue to shoulder the burden of care, often beyond healthful limits, while others relinquish care to professionals is examined longitudinally in a sample of 209 caregivers. Using logistic regression techniques, caregiver characteristics and caregiver well-being, rather than patient characteristics, emerge as important predictors of placement decisions. Results suggest that practitioners, in evaluating the family's need for institutionalization, must move beyond duration of illness and current cognitive functioning to aspects of the caregiver support system.
                Bookmark

                Author and article information

                Journal
                American Journal of Public Health
                Am J Public Health
                American Public Health Association
                0090-0036
                1541-0048
                August 1994
                August 1994
                : 84
                : 8
                : 1261-1264
                Article
                10.2105/AJPH.84.8.1261
                1615456
                8059882
                © 1994

                Molecular medicine, Neurosciences

                Comments

                Comment on this article